'Davao Death Squad' men, CHR summoned to Senate probe on Sept. 28 | Inquirer News

‘Davao Death Squad’ men, CHR summoned to Senate probe on Sept. 28

Edgar Matobato

SEPTEMBER 22, 2016:  Lone witness Edgar Matobato testifies during the hearing on extrajudicial killings of drug suspects at the Senate Session Hall.  INQUIRER PHOTO/LYN RILLON

MANILA — The Senate committee on justice and human rights has set its next hearing of the alleged extrajudicial killings of drug suspects in the ongoing government war on drugs on Sept. 28.

This was announced by the committee chair, Sen. Richard Gordon, after the suspension Thursday night of his committee hearing. Gordon said he would hold two or three more hearings before concluding its inquiry.

ADVERTISEMENT

To be invited to the next hearing are officials and witnesses of the Commission on Human Rights as well as the alleged 23 members of the Davao Death Squad, mostly policemen, identified by confessed hitman Edgar Maboto as his cohorts in executing criminals in Davao City, allegedly on orders from President Duterte when he was still mayor of Davao City.

FEATURED STORIES

Summoned to the hearing was SPO4 Arturo Lascañas whom Matobato said was the leader of the death squad.

Sen. Panfilo Lacson said senators would hold a caucus on Monday (Sept. 26) to talk about how to go about in dealing with the alleged DDS members. He had proposed to hold an executive session to hear their testimony.  SFM

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: CHR, congressional inquiries, Crime, Davao City, drug pushing, Drug trafficking, Hitmen, Human rights, Justice, law, mayor, Murder, Nation, News, Police, purge, Regions, rubout, Senate, Shooting, Shootout, war on drugs, war vs drugs

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.